Skip to main content
Erschienen in: International Urology and Nephrology 7/2014

01.07.2014 | Urology - Original Paper

Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes

verfasst von: Min-Shen Chung, Yao-Chi Chuang, Jong-Jer Lee, Wei-Chia Lee, Michael B. Chancellor, Rue-Tsuan Liu

Erschienen in: International Urology and Nephrology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the correlates of nocturia and subsequent mortality in patients with type 2 diabetes mellitus (T2DM).

Methods

A self-administered questionnaire containing overactive bladder symptom score was obtained from subjects with T2DM. Nocturia and severe nocturia were defined as rising ≥2 or ≥3 per night to void, respectively. Patient characteristics and diabetes-related complications to risk of nocturia were evaluated.

Results

Of 1,301 consecutive subjects, 59.6 and 25.3 % reported having nocturia and severe nocturia, respectively. The presence and severity of nocturia increased with age and overactive bladder (OAB). The presence of OAB was 28.8 % in patients with nocturia and was significantly associated with nocturia (OR 2.26) after adjustment for age and duration of DM. The presence of stroke, calcium channel blocker use, hypertension, waist circumference greater than standard, albuminuria, and higher serum creatinine level, and high-sensitivity C-reactive protein was associated with nocturia and severe nocturia after adjustment for age, duration of DM, and the presence of OAB. Higher estimated glomerular filtration rate, hemoglobin, serum albumin, and male gender were less likely to have nocturia (OR <1). Severe nocturia increased mortality (OR 1.93) independent of age and DM duration and has a higher mortality rate compared to those without severe nocturia (6.1 vs. 2.4 %, P = 0.001) in 2.5 years follow-up.

Conclusions

While OAB is an important predictor of nocturia in T2DM patients, systemic issues, including stroke, hypertension, obesity, and chronic kidney disease, have further impact on nocturia independent of OAB. Severe nocturia is a marker for increased mortality.
Literatur
1.
Zurück zum Zitat van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee of the international continence society. Neurourol Urodynam 21:179–183CrossRef van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee of the international continence society. Neurourol Urodynam 21:179–183CrossRef
2.
Zurück zum Zitat van Dijk L, Kooij DG, Schellevis FG (2002) Nocturia in the Dutch adult population. BJU Int 90:644–648PubMedCrossRef van Dijk L, Kooij DG, Schellevis FG (2002) Nocturia in the Dutch adult population. BJU Int 90:644–648PubMedCrossRef
3.
Zurück zum Zitat Fitzgerald MP, Litman HJ, Link CL, McKinlay JB (2007) The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 177:1385–1389PubMedCrossRef Fitzgerald MP, Litman HJ, Link CL, McKinlay JB (2007) The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 177:1385–1389PubMedCrossRef
4.
Zurück zum Zitat Ruud Bosch JLH, Weiss JP (2010) The prevalence and causes of nocturia. J Urol 184:440–446CrossRef Ruud Bosch JLH, Weiss JP (2010) The prevalence and causes of nocturia. J Urol 184:440–446CrossRef
5.
Zurück zum Zitat Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1315PubMedCrossRef Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1315PubMedCrossRef
6.
Zurück zum Zitat Liu RT, Chung MS, Lee WC et al (2011) Prevalence of overactive bladder (OAB) and associated risk factors in 1,359 patients with type 2 diabetes. Urology 78:1040–1045PubMedCrossRef Liu RT, Chung MS, Lee WC et al (2011) Prevalence of overactive bladder (OAB) and associated risk factors in 1,359 patients with type 2 diabetes. Urology 78:1040–1045PubMedCrossRef
7.
Zurück zum Zitat Gulur DM, Mevcha AM, Drake MJ (2011) Nocturia as a manifestation of systemic disease. BJU Int 107:702–713PubMedCrossRef Gulur DM, Mevcha AM, Drake MJ (2011) Nocturia as a manifestation of systemic disease. BJU Int 107:702–713PubMedCrossRef
8.
Zurück zum Zitat Yoshimura K (2012) Correlates for nocturia: a review of epidemiological studies. Int J Urol 19:317–329PubMedCrossRef Yoshimura K (2012) Correlates for nocturia: a review of epidemiological studies. Int J Urol 19:317–329PubMedCrossRef
9.
Zurück zum Zitat Yamaguchi C, Sakakibara R, Uchiyama T et al (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodynam 26:807–813CrossRef Yamaguchi C, Sakakibara R, Uchiyama T et al (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodynam 26:807–813CrossRef
10.
Zurück zum Zitat Yoshimura N, Chancellor MB, Andersson KE et al (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733–738PubMedCrossRef Yoshimura N, Chancellor MB, Andersson KE et al (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733–738PubMedCrossRef
11.
Zurück zum Zitat Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology 68:318–323PubMedCrossRef Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology 68:318–323PubMedCrossRef
12.
Zurück zum Zitat Liew LC, Tiong HY, Wong ML et al (2006) A population study of nocturia in Singapore. BJU Int 97:109–112PubMedCrossRef Liew LC, Tiong HY, Wong ML et al (2006) A population study of nocturia in Singapore. BJU Int 97:109–112PubMedCrossRef
13.
Zurück zum Zitat Tibaek S, Gard G, Klarskov P et al (2008) Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn 27:763–771PubMedCrossRef Tibaek S, Gard G, Klarskov P et al (2008) Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn 27:763–771PubMedCrossRef
14.
16.
17.
Zurück zum Zitat Tai HC, Chung SD, Ho CH et al (2010) Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 95:1143–1150PubMedCrossRef Tai HC, Chung SD, Ho CH et al (2010) Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 95:1143–1150PubMedCrossRef
18.
Zurück zum Zitat Wu MY, Wu YL, Hsu YH, Lin YF, Fan YC, Lin YC, Chang SJ (2012) Risks of nocturia in patients with chronic kidney disease- doe the metabolic syndrome and its components matter? J Urol 188:2269–2273PubMedCrossRef Wu MY, Wu YL, Hsu YH, Lin YF, Fan YC, Lin YC, Chang SJ (2012) Risks of nocturia in patients with chronic kidney disease- doe the metabolic syndrome and its components matter? J Urol 188:2269–2273PubMedCrossRef
19.
Zurück zum Zitat Kupelian V, McVary KT, Barry MJ et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Bostonarea community health survey. Urology 73:950–957PubMedCentralPubMedCrossRef Kupelian V, McVary KT, Barry MJ et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Bostonarea community health survey. Urology 73:950–957PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Lu Z, Gao Y, Tan A et al (2012) Increased high-sensitivity C-reactive protein predicts a high risk of lower urinary tract symptoms in Chinese male: results from the Fangchenggang Area Male Health and Examination Survey. Prostate 72:193–200PubMedCrossRef Lu Z, Gao Y, Tan A et al (2012) Increased high-sensitivity C-reactive protein predicts a high risk of lower urinary tract symptoms in Chinese male: results from the Fangchenggang Area Male Health and Examination Survey. Prostate 72:193–200PubMedCrossRef
21.
Zurück zum Zitat van Doorn B, Kok ET, Blanker MH et al (2012) Mortality in older men with nocturia. A 15-year followup of the Krimpen study. J Urol 187:1727–1731PubMedCrossRef van Doorn B, Kok ET, Blanker MH et al (2012) Mortality in older men with nocturia. A 15-year followup of the Krimpen study. J Urol 187:1727–1731PubMedCrossRef
22.
Zurück zum Zitat Kupelian V, Fitzgerald MP, Kaplan SA et al (2011) Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol 185:571–577PubMedCrossRef Kupelian V, Fitzgerald MP, Kaplan SA et al (2011) Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol 185:571–577PubMedCrossRef
23.
Zurück zum Zitat Asplund R (1999) Mortality in the elderly in relation to nocturnal micturition. BJU Int 84:297–301PubMedCrossRef Asplund R (1999) Mortality in the elderly in relation to nocturnal micturition. BJU Int 84:297–301PubMedCrossRef
Metadaten
Titel
Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes
verfasst von
Min-Shen Chung
Yao-Chi Chuang
Jong-Jer Lee
Wei-Chia Lee
Michael B. Chancellor
Rue-Tsuan Liu
Publikationsdatum
01.07.2014
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 7/2014
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0669-2

Weitere Artikel der Ausgabe 7/2014

International Urology and Nephrology 7/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.